Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

C225 + radiotherapy produces 100% response rate in head and neck cancer

May 19, 1998

Cytokine suppressants: an effective approach to the treatment of cancer cachexia

May 19, 1998

Phase I toxicity and efficacy results for CT-2584 presented at ASCO meeting

May 19, 1998

Matrix proceeds with full enrollment for IntraDose phase II trials

May 19, 1998

Batimastat enhances antitumor activity of cisplatin against ovarian cancer

May 19, 1998

Mechanism of antitumor activity of clotrimazole identified

May 18, 1998

U.S. patent issues for ImClone Systems' flk-1/KDR receptor-targeting antibodies

May 18, 1998

SU-5416 advances to phase I/II trials in Kaposi's sarcoma

May 18, 1998

Rhone-Poulenc Rorer expands licensing agreement with Enzon for Oncaspar

May 18, 1998

Sanofi receives expanded approval for oxaliplatin in France

May 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...